Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Proteomic Precision Diagnosis Model for Early Stage Lung Cancer

NCT06733311 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT06733311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06733311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Proteomic Precision Diagnosis Model for Early Stage Lung Cancer
Lead sponsor
Beijing Chao Yang Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2024
Completion date
December 31, 2024
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage lung cancer, nsclc, pulmonary nodule